TGI/CIV
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TGI/CIV, covering 2025-02-10 to 2025-02-10. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of the Efficacy and Safety of Pazopanib in Combination with TGI/CIV for Recurrent or Refractory Rhabdomyosarcoma in Children or Adolescents [Phase 2]